Zotarolimus-versus everolimus-eluting stents for unprotected left main coronary artery disease

Journal of the American College of Cardiology

Volumn 62, Issue 22, 2013, Pages 2075-2082

  Mehilli, Julinda ^a   Richardt, Gert ^b   Valgimigli, Marco ^c   Schulz, Stefanie ^d   Singh, Ambika ^d   Abdel Wahab, Mohamed ^b   Tiroch, Klaus ^e   Pache, Jürgen ^f   Hausleiter, Jörg ^a   Byrne, Robert A ^d   Ott, Ilka ^d   Ibrahim, Tareq ^g   Fusaro, Massimiliano ^d   Seyfarth, Melchior ^e   Laugwitz, Karl Ludwig ^g   Massberg, Steffen ^a   Kastrati, Adnan ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Bad Segeberger Kliniken   (Germany)

^c UNIVERSITY OF FERRARA   (Italy)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e HELIOS KLINIKUM WUPPERTAL   (Germany)

^f Schön Clinic   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

coronary artery disease; drug eluting stent(s); everolimus; left main coronary artery; restenosis; zotarolimus

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STENT THROMBOSIS; UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE;

EID: 84888210834     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.044     Document Type: Article

References (27)

1. V. Farooq, D. van Klaveren, and E.W. Steyerberg Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II Lancet 381 2013 639 650
2. A. Chieffo, E. Meliga, and A. Latib Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment J Am Coll Cardiol Intv 5 2012 718 727
3. A.P. Kappetein, T.E. Feldman, and M.J. Mack Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
4. K. Chang, Y.S. Koh, and S.H. Jeong Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era Heart 98 2012 799 805
5. D. Capodanno, A. Caggegi, and P. Capranzano Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus >/=75 years with unprotected left main disease (from the CUSTOMIZE Registry) Am J Cardiol 110 2012 1452 1458
6. M. Alam, H.D. Huang, and S.A. Shahzad Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era - an aggregate data meta-analysis of 11,148 patients Circ J 77 2013 372 382
7. U. Baber, R. Mehran, and S.K. Sharma Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials J Am Coll Cardiol 58 2011 1569 1577
8. Y.H. Kim, D.W. Park, and J.M. Ahn Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study J Am Coll Cardiol Intv 5 2012 708 717
9. C. von Birgelen, M.W. Basalus, and K. Tandjung A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial J Am Coll Cardiol 59 2012 1350 1361
10. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
11. V. Parsonnet, D. Dean, and A.D. Bernstein A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease Circulation 79 1989 I3 12
12. P. Michel, F. Roques, and S.A. Nashef Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23 2003 684 687 discussion 687
13. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
14. J.M. Brennan, D. Dai, and M.R. Patel Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008 J Am Coll Cardiol 59 2012 648 654
15. J. Mehilli, A. Kastrati, and R.A. Byrne Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease J Am Coll Cardiol 53 2009 1760 1768
16. M.M. Vis, M.A. Beijk, and M.J. Grundeken A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction J Am Coll Cardiol Intv 6 2013 317 324
17. S. Desch, E. Boudriot, and A. Rastan Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. A meta-analysis of randomized controlled trials Herz 38 2013 48 56
18. S.J. Park, Y.H. Kim, and D.W. Park Randomized trial of stents versus bypass surgery for left main coronary artery disease N Engl J Med 364 2011 1718 1727
19. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
20. A.P. Banning, S. Westaby, and M.C. Morice Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 2010 1067 1075
21. S. Bangalore, S. Kumar, and M. Fusaro Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
22. D. Hildick-Smith, A.J. de Belder, and N. Cooter Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies Circulation 121 2010 1235 1243
23. D.W. Park, Y.H. Kim, and S.C. Yun Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention Eur Heart J 34 2013 1662 1669
24. W. Ng, R. Lundstrom, and E. McNulty Impact of stenting technique and bifurcation anatomy on long-term outcomes of PCI for distal unprotected left main coronary disease J Invasive Cardiol 25 2013 23 27
25. S. Massberg, R.A. Byrne, and A. Kastrati Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial Circulation 124 2011 624 632
26. R.A. Byrne, A. Kastrati, and S. Kufner Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Eur Heart J 30 2009 2441 2449
27. T. Tada, R.A. Byrne, and S. Cassese Comparative efficacy of 2 zotarolimus-eluting stent generations: resolute versus endeavor stents in patients with coronary artery disease Am Heart J 165 2013 80 86